object
coronaviru
diseas
escal
global
epidem
caus
high
mortal
critic
patient
effect
indic
predict
diseas
sever
infect
patient
urgent
need
method
studi
patient
admit
chongq
public
health
medic
center
involv
demograph
data
clinic
featur
laboratori
examin
obtain
electron
medic
record
peripher
blood
specimen
collect
patient
examin
lymphocyt
subset
cytokin
profil
flow
cytometri
potenti
contribut
factor
predict
diseas
sever
analyz
result
total
patient
includ
studi
includ
mild
patient
sever
patient
sever
patient
significantli
older
vs
higher
incid
coinfect
bacteria
compar
mild
group
significantli
sever
patient
clinic
symptom
anhel
asthma
laboratori
examin
sever
case
show
signific
reduct
lymphocyt
count
level
erythrocyt
sediment
rate
esr
ddimer
dd
significantli
higher
sever
patient
mild
patient
level
albumin
alb
remark
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
medrxiv
preprint
lower
sever
patient
analysi
demonstr
esr
dd
age
alb
major
contribut
factor
distinguish
sever
patient
mild
patient
moreov
esr
identifi
power
factor
predict
diseas
progress
patient
age
level
esr
dd
alb
close
relat
diseas
sever
patient
esr
use
valuabl
indic
distinguish
sever
patient
earli
stage
increas
surviv
sever
patient
coronavirus
possess
singl
strand
positivesens
rna
genom
belong
famili
coronavirida
human
coronavirus
associ
mild
clinic
symptom
infect
except
two
betacoronavirus
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
sever
acut
respiratori
syndrom
coronaviru
newli
recognis
coronaviru
emerg
wuhan
decemb
caus
cluster
sever
respiratori
diseas
recent
name
corona
viru
diseas
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doiorg
world
health
organ
march
total
number
confirm
patient
mainland
china
death
confirm
recent
studi
clinic
characterist
patient
show
common
clinic
symptom
fever
cough
fatigu
pneumonia
mild
patient
sever
patient
could
develop
acut
respiratori
distress
syndrom
even
organ
failur
patient
moder
symptom
especi
elderli
one
comorbid
worsen
result
high
mortal
sever
studi
report
role
inflammationrel
biomark
diseas
progress
patient
studi
critic
ill
patient
pneumonia
demonstr
lymphocytopenia
reflect
sever
infect
consist
studi
li
tan
et
al
suggest
lymphocytopenia
use
use
prognost
factor
sever
patient
recent
studi
also
demonstr
decreas
lymphocyt
increas
inflammatori
cytokin
level
patient
suggest
cell
ratio
level
indic
earli
identif
sever
patient
line
studi
huang
c
et
al
report
patient
intens
care
unit
icu
manifest
higher
express
cytokin
includ
gscf
tnf
compar
nonicu
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doiorg
patient
howev
correl
express
clinic
paramet
diseas
sever
still
larg
unclear
studi
aim
analyz
differ
characterist
lymphocyt
subset
cytokin
level
mild
sever
patient
screen
suitabl
indic
predict
diseas
sever
order
provid
guidanc
subsequ
clinic
intervent
mild
patient
follow
condit
fever
respiratori
symptom
ct
imag
typic
viral
pneumonia
rna
posit
rtpcr
examin
sever
patient
least
one
follow
condit
addit
met
respiratori
distress
rr
timesminut
oxygen
satur
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doiorg
rest
state
oxygen
partial
pressur
oxygen
concentr
arteri
studi
approv
chongq
public
health
medic
center
ethic
committe
written
inform
consent
waiv
due
anonym
analysi
clinic
data
obtain
clinic
featur
patient
center
electron
medic
record
includ
demograph
inform
clinic
symptom
laboratori
analys
clinic
laboratori
investig
includ
whole
blood
count
serum
biochem
test
includ
liver
renal
function
lactat
dehydrogenas
electrolyt
creatin
kinas
coagul
test
creactiv
protein
procalcitonin
nucleic
acid
test
respiratori
specimen
includ
throat
swab
specimen
bronchoalveolar
lavag
fluid
sputum
test
rna
use
real
time
rtpcr
kit
chongq
zhongyuanhuiji
biotechnolog
limit
chongq
china
recommend
chines
center
diseas
control
prevent
cdc
bacteri
fungal
pathogen
microorgan
examin
also
routin
perform
data
check
independ
two
research
ascertain
accuraci
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doiorg
peripher
blood
sampl
collect
involv
patient
lymphocyt
subset
cytokin
test
lymphocyt
test
kit
hangzhou
cellgen
biotechnolog
limit
hangzhou
china
use
lymphocyt
subset
analysi
cytokin
profil
detect
human
cytokin
kit
jiangxi
cellgen
biotechnolog
limit
jiangxi
china
test
perform
accord
product
manual
categor
variabl
express
count
percentag
signific
detect
fisher
exact
test
differ
categori
quantiz
variabl
paramet
describ
mean
standard
deviat
normal
distribut
signific
test
ttest
express
median
quartil
interv
normal
distribut
signific
test
wilcoxon
ranksum
test
twosid
p
valu
less
consid
statist
signific
least
absolut
shrinkag
select
oper
lasso
analysi
use
identifi
major
contribut
factor
among
clinic
paramet
differenti
mild
sever
patient
predict
valu
select
paramet
distinguish
patient
mild
sever
symptom
evalu
receiv
oper
characterist
roc
area
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doiorg
roc
curv
auc
statist
analys
done
use
stata
softwar
version
r
packag
version
total
patient
enrol
studi
includ
mild
patient
sever
patient
accord
mention
condit
patient
consist
femal
patient
male
patient
medium
age
sever
patient
significantli
higher
mild
patient
vs
p
half
patient
exposur
histori
includ
wuhan
contact
histori
personnel
return
wuhan
total
patient
underli
diseas
includ
hypertens
diabet
tuberculosi
rheumat
heart
signific
differ
observ
mild
sever
group
sever
patient
much
higher
opportun
bacteri
coinfect
mild
patient
p
sever
patient
mild
patient
fever
significantli
sever
patient
temperatur
degre
clinic
symptom
sever
patient
much
higher
frequenc
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doiorg
occurr
chest
distress
anhel
asthma
tabl
lymphocyt
subset
detect
significantli
decreas
cell
count
observ
sever
patient
signific
differ
ratio
two
group
routin
blood
test
sever
patient
show
significantli
increas
number
percentag
tabl
liver
kidney
function
sever
patient
show
significantli
higher
express
aspart
aminotransferas
ast
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doiorg
lactat
dehydrogenas
ldh
p
globulin
glo
cystatin
c
cysc
hydroxybutyr
dehydrogenas
hbdh
thyrogloblin
tg
glucos
glu
show
significantli
lower
level
albumin
alb
albuminglobulin
ag
p
uric
acid
ua
glomerular
filtrat
rate
egfr
k
compar
mild
group
tabl
infect
index
express
creactiv
protein
crp
p
erythrocyt
sediment
rate
esr
p
significantli
elev
sever
patient
mild
patient
analysi
plasma
cytokin
demonstr
median
concentr
sever
group
higher
mild
group
level
p
increas
significantli
compar
mild
patient
signific
differ
level
observ
two
group
tabl
furthermor
cell
ratio
neutrophiltolymphocyt
ratio
nlr
ratio
neutrophil
ratiotolymphocyt
ratio
nrlr
significantli
higher
sever
patient
mild
patient
ratio
significantli
decreas
sever
patient
p
data
show
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doiorg
next
identifi
potenti
contribut
factor
distinguish
mild
sever
patient
use
mention
paramet
crossvalid
via
minimum
criteria
firstli
perform
defin
tune
paramet
lasso
model
figur
recent
sever
studi
focu
immunolog
characterist
potenti
factor
monitor
diseas
sever
patient
howev
knowledg
role
clinic
paramet
involv
patient
still
insuffici
studi
evalu
clinic
immunolog
characterist
confirm
patient
admit
chongq
public
health
medic
center
chongq
screen
potenti
factor
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doiorg
effect
indic
diseas
progress
order
provid
appropri
treatment
sever
patient
earli
compar
mild
patient
sever
patient
older
higher
frequenc
coinfect
bacteria
consist
previou
report
critic
ill
patient
like
older
coinfect
bacteria
furthermor
sever
patient
like
chest
distress
respiratori
symptom
anhel
asthma
clinic
symptom
patient
similar
report
studi
term
laboratori
find
esr
crp
aptt
dd
alb
ast
ldh
fib
significantli
higher
sever
case
mild
case
indic
degre
cardiac
live
coagul
function
abnorm
infect
attent
paid
patient
avoid
delay
treatment
studi
sever
patient
like
develop
lymphopenia
mild
patient
consist
previou
studi
sever
patient
higher
rate
lymphopenia
lymphopenia
also
observ
sarscov
merscov
infect
patient
differ
mechan
consist
previou
studi
also
observ
decreas
absolut
number
cell
sever
mild
patient
moreov
number
cell
markedli
lower
sever
patient
mild
patient
far
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doiorg
potenti
mechan
lymphopenia
particularli
decreas
cell
count
patient
remain
unclear
might
direct
influenc
lymphocyt
lymphat
organ
indirect
pathway
correspond
mechan
warrant
investig
previou
studi
patient
demonstr
cytokin
storm
syndrom
cr
could
happen
infect
patient
cytokin
storm
quickli
induc
organ
failur
threaten
life
patient
regard
import
caus
death
patient
recent
studi
report
increas
serum
cytokin
level
patient
especi
sever
patient
suggest
cytokin
storm
associ
diseas
sever
studi
sever
patient
occur
elev
level
mild
patient
furthermor
level
sever
group
significantli
higher
mild
group
analysi
demonstr
variat
close
relat
diseas
progress
patient
result
consist
previou
studi
suggest
effect
target
diseas
monitor
treatment
acut
phase
inflammatori
cytokin
play
import
role
regul
inflammatori
respons
elev
level
often
observ
patient
acut
respiratori
distress
syndrom
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doiorg
may
relat
lymphocyt
damag
howev
underli
mechan
cytokin
involv
patient
need
investig
result
indic
infectionrel
factor
esr
also
significantli
higher
sever
patient
compar
mild
patient
consist
previou
studi
esr
simpl
laboratori
test
evalu
inflammatori
acut
respons
state
previou
studi
report
symptom
sign
plu
esr
predict
pneumonia
effect
esr
also
use
monitor
factor
diagnosi
manag
gemcitabineinduc
pulmonari
toxic
furthermor
esr
report
power
predictor
coronari
heart
diseas
howev
exact
role
esr
patient
still
controversi
studi
gong
et
al
indic
esr
unrel
diseas
sever
patient
pneumonia
earli
examin
risk
factor
patient
could
distinguish
sever
patient
mild
patient
effect
facilit
appropri
treatment
recent
studi
report
sever
factor
may
relat
sever
patient
includ
lymphopenia
nlr
although
also
observ
higher
frequenc
occurr
lymphopenia
sever
patient
potenti
factor
predict
sever
patient
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doiorg
accord
lasso
binari
logist
regress
analysi
liu
et
al
indic
even
better
perform
nlr
roc
curv
analysi
studi
also
significantli
higher
sever
patient
unfortun
cut
sinc
result
lasso
binari
logist
regress
analysi
result
demonstr
potenti
marker
identifi
sever
patient
esr
dd
age
alb
lasso
binari
logist
regress
analysi
esr
best
perform
higher
auc
valu
roc
curv
analysi
therefor
esr
use
power
indic
predict
diseas
sever
infect
patient
conclus
studi
provid
correl
clinic
paramet
diseas
sever
patient
studi
mild
sever
patient
demonstr
clinic
paramet
includ
esr
dd
age
alb
close
relat
diseas
progress
patient
among
paramet
esr
best
perform
use
effect
indic
predict
sever
diseas
studi
may
help
identifi
sever
patient
earli
stage
order
provid
support
treatment
reduc
mortal
work
support
introduct
talent
program
chongq
medic
pharmaceut
colleg
joint
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doiorg
commiss
author
report
conflict
interest
work
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doiorg
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doiorg
pt
median
iqr
